286 related articles for article (PubMed ID: 21821523)
1. No-reflow phenomenon: maintaining vascular integrity.
Kloner RA
J Cardiovasc Pharmacol Ther; 2011; 16(3-4):244-50. PubMed ID: 21821523
[TBL] [Abstract][Full Text] [Related]
2. Coronary no reflow.
Schwartz BG; Kloner RA
J Mol Cell Cardiol; 2012 Apr; 52(4):873-82. PubMed ID: 21712046
[TBL] [Abstract][Full Text] [Related]
3. The reduction of infarct size--forty years of research.
Ferreira R
Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
[TBL] [Abstract][Full Text] [Related]
4. No reflow phenomenon in coronary heart disease.
Ito H
J Cardiol; 2001; 37 Suppl 1():39-42. PubMed ID: 11433826
[TBL] [Abstract][Full Text] [Related]
5. Management of the no-reflow phenomenon.
Butler MJ; Chan W; Taylor AJ; Dart AM; Duffy SJ
Pharmacol Ther; 2011 Oct; 132(1):72-85. PubMed ID: 21664376
[TBL] [Abstract][Full Text] [Related]
6. The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit.
Hale SL; Kloner RA
J Cardiovasc Pharmacol Ther; 2008 Sep; 13(3):226-32. PubMed ID: 18625805
[TBL] [Abstract][Full Text] [Related]
7. Reperfusion injury in acute myocardial infarction: from bench to cath lab. Part II: Clinical issues and therapeutic options.
Monassier JP
Arch Cardiovasc Dis; 2008 Sep; 101(9):565-75. PubMed ID: 19041841
[TBL] [Abstract][Full Text] [Related]
8. Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach.
Jaffe R; Dick A; Strauss BH
JACC Cardiovasc Interv; 2010 Jul; 3(7):695-704. PubMed ID: 20650430
[TBL] [Abstract][Full Text] [Related]
9. No-reflow phenomenon and prognosis in patients with acute myocardial infarction.
Ito H
Nat Clin Pract Cardiovasc Med; 2006 Sep; 3(9):499-506. PubMed ID: 16932767
[TBL] [Abstract][Full Text] [Related]
10. [Effect of urapidil on heart function and ventricular systolic synchrony in acute myocardial infarction patients with no-reflow phenomenon after percutaneous coronary intervention].
Chen JL; Fu XH; Jiang YF; Fan WZ; Gu XS; Liu JJ; Geng W
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Apr; 20(4):197-9. PubMed ID: 18419949
[TBL] [Abstract][Full Text] [Related]
11. New strategies for the management of no-reflow after primary percutaneous coronary intervention.
Niccoli G; Cosentino N; Spaziani C; Minelli S; Fracassi F; Crea F
Expert Rev Cardiovasc Ther; 2011 May; 9(5):615-30. PubMed ID: 21615325
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging.
Eitel I; Nowak M; Stehl C; Adams V; Fuernau G; Hildebrand L; Desch S; Schuler G; Thiele H
Am Heart J; 2010 May; 159(5):882-90. PubMed ID: 20435200
[TBL] [Abstract][Full Text] [Related]
13. Effect of Elevated Reperfusion Pressure on "No Reflow" Area and Infarct Size in a Porcine Model of Ischemia-Reperfusion.
Pantsios C; Kapelios C; Vakrou S; Diakos N; Pozios I; Kontogiannis C; Nanas J; Malliaras K
J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):405-11. PubMed ID: 26589289
[TBL] [Abstract][Full Text] [Related]
14. The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion.
Reffelmann T; Kloner RA
Basic Res Cardiol; 2006 Sep; 101(5):359-72. PubMed ID: 16915531
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
Ndrepepa G; Tiroch K; Keta D; Fusaro M; Seyfarth M; Pache J; Mehilli J; Schömig A; Kastrati A
Circ Cardiovasc Interv; 2010 Feb; 3(1):27-33. PubMed ID: 20118156
[TBL] [Abstract][Full Text] [Related]
16. The no-reflow phenomenon: epidemiology, pathophysiology, and therapeutic approach.
Alfayoumi F; Srinivasan V; Geller M; Gradman A
Rev Cardiovasc Med; 2005; 6(2):72-83. PubMed ID: 15976730
[TBL] [Abstract][Full Text] [Related]
17. Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia/reperfusion model.
Dai W; Hale S; Kloner RA
Int J Cardiol; 2017 Jun; 236():400-404. PubMed ID: 28108128
[TBL] [Abstract][Full Text] [Related]
18. Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion.
Hale SL; Mehra A; Leeka J; Kloner RA
Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H421-5. PubMed ID: 17993599
[TBL] [Abstract][Full Text] [Related]
19. Myocardial 'no-reflow' prevention.
Magro M; Springeling T; van Geuns RJ; Zijlstra F
Curr Vasc Pharmacol; 2013 Mar; 11(2):263-77. PubMed ID: 23506503
[TBL] [Abstract][Full Text] [Related]
20. [Beneficial effects of nicorandil on myocardial no-reflow state in a mini-swine model of acute myocardial infarction and reperfusion].
Zhao JL; Yang YJ; You SJ; Jing ZC; Wu YJ; Yang WX; Meng L; Tian Y; Chen JL; Gao RL; Chen ZJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Jul; 17(7):421-5. PubMed ID: 16004786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
